Clinical trial Recruiting at 1 site Interventional Ages 18 to 84

HFNC vs Microstream nasal cannula during ERCP

Official title: HFNC Versus Microstream Advance Nasal Cannula for Oxygenation During ERCP

Run by Kocaeli University · NCT07611903 · Data updated 2026-11-12

This study compares high-flow nasal oxygen with the Microstream Advance nasal cannula to see which one better keeps patients’ oxygen levels stable during ERCP procedures done under deep sedation.

Quick facts

Study typeInterventional
Ages18 Years to 84 Years
SexAll
Enrollment74 (estimated)
SponsorKocaeli University
Academic / other
Locations1 site (Kocaeli, Umuttepe)
StatusRecruiting
StartedJuly 14, 2026
Main results expectedNovember 30, 2026
Study endsDecember 30, 2026
Registry record updatedJuly 15, 2026
Trial IDNCT07611903 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–84 years old with ASA I–III undergoing ERCP, without recent upper respiratory infection, COPD, asthma, lung cancer, BMI >35, and who consent to participate.

Probably not a fit

Patients with severe oxygenation issues beyond the scope of standard support or those not responding to either device may gain no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective randomized trial tests two oxygen delivery methods during ERCP procedures: high-flow nasal cannula (HFNC) and the Microstream Advance nasal cannula. Participants are adults with ASA I–III scheduled for ERCP and randomized to receive oxygen support with one of the two devices while sedated. Primary outcomes include rate of desaturation and oxygen reserve index during the procedure; secondary outcomes cover time to reach target ORi, respiratory complications, and procedure-related adverse events. The study is conducted at a single center, with Kocaeli University as the lead sponsor. Enrollment targets adults aged 18 to 84 without active lung disease or BMI >35 kg/m², and who provide informed consent.

Why it matters

Potential benefit: If successful, the preferred oxygen delivery method could reduce hypoxemia during ERCP and improve patient safety.

How similar studies have gone: Past studies in other procedures suggest oxygen delivery methods can impact oxygenation, but direct evidence for this comparison in ERCP is limited, making results informative though not guaranteed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 18 to 84 years
* ASA physical status I-III
* Patients scheduled to undergo ERCP
* Patients who provide written informed consent

Exclusion Criteria:

* Recent history of upper respiratory tract infection
* History of lung cancer
* Chronic obstructive pulmonary disease
* Asthma
* Body mass index greater than 35 kg/m²
* Refusal to participate in the study

Where it's running

  • Kocaeli University Faculty of Medicine Hospital
    Kocaeli, Umuttepe, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Volkan Alparslan, M.D. — Kocaeli University
  • Study coordinator: Volkan Alparslan, M.D.
  • Email: volknn@hotmail.com
  • Phone: 05059374578

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.